1. Home
  2. CGON vs WBTN Comparison

CGON vs WBTN Comparison

Compare CGON & WBTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • WBTN
  • Stock Information
  • Founded
  • CGON 2010
  • WBTN 2005
  • Country
  • CGON United States
  • WBTN United States
  • Employees
  • CGON N/A
  • WBTN N/A
  • Industry
  • CGON
  • WBTN
  • Sector
  • CGON
  • WBTN
  • Exchange
  • CGON NYSE
  • WBTN NYSE
  • Market Cap
  • CGON 1.3B
  • WBTN 1.2B
  • IPO Year
  • CGON 2024
  • WBTN 2024
  • Fundamental
  • Price
  • CGON $25.62
  • WBTN $8.79
  • Analyst Decision
  • CGON Strong Buy
  • WBTN Buy
  • Analyst Count
  • CGON 10
  • WBTN 6
  • Target Price
  • CGON $64.00
  • WBTN $12.92
  • AVG Volume (30 Days)
  • CGON 1.4M
  • WBTN 405.9K
  • Earning Date
  • CGON 05-13-2025
  • WBTN 05-13-2025
  • Dividend Yield
  • CGON N/A
  • WBTN N/A
  • EPS Growth
  • CGON N/A
  • WBTN N/A
  • EPS
  • CGON N/A
  • WBTN N/A
  • Revenue
  • CGON $662,000.00
  • WBTN $1,347,441,000.00
  • Revenue This Year
  • CGON N/A
  • WBTN $9.09
  • Revenue Next Year
  • CGON $12,387.03
  • WBTN $15.09
  • P/E Ratio
  • CGON N/A
  • WBTN N/A
  • Revenue Growth
  • CGON 224.51
  • WBTN 3.71
  • 52 Week Low
  • CGON $14.80
  • WBTN $6.75
  • 52 Week High
  • CGON $40.47
  • WBTN $25.66
  • Technical
  • Relative Strength Index (RSI)
  • CGON 53.27
  • WBTN N/A
  • Support Level
  • CGON $24.79
  • WBTN N/A
  • Resistance Level
  • CGON $26.60
  • WBTN N/A
  • Average True Range (ATR)
  • CGON 1.39
  • WBTN 0.00
  • MACD
  • CGON -0.01
  • WBTN 0.00
  • Stochastic Oscillator
  • CGON 48.52
  • WBTN 0.00

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About WBTN WEBTOON ENTERTAINMENT INC

Webtoon Entertainment Inc is a global storytelling platform where a vibrant community of creators and users discover, create and share new content. It has pioneered a cultural movement by revolutionizing the storytelling format and democratizing content creation and publication connecting 24 million creators with approximately 170 million monthly active users in over 150 countries around the world.

Share on Social Networks: